dc.contributor.author | Phyu, Su M | |
dc.contributor.author | Tseng, Chih-Chung Tseng | |
dc.contributor.author | Fleming, Ian N | |
dc.contributor.author | Smith, Tim A D | |
dc.date.accessioned | 2016-11-04T11:30:37Z | |
dc.date.available | 2016-11-04T11:30:37Z | |
dc.date.issued | 2016-11-04 | |
dc.identifier | 72201759 | |
dc.identifier | 19427b35-9a10-43a2-9774-ea4e9945b713 | |
dc.identifier | 84994651665 | |
dc.identifier.citation | Phyu , S M , Tseng , C-C T , Fleming , I N & Smith , T A D 2016 , ' Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy : routes to glycogen synthase kinase 3 ' , Scientific Reports , vol. 6 , 36544 . https://doi.org/10.1038/srep36544 | en |
dc.identifier.issn | 2045-2322 | |
dc.identifier.other | ORCID: /0000-0003-0338-8664/work/35515838 | |
dc.identifier.other | ORCID: /0000-0001-9505-6418/work/86450281 | |
dc.identifier.uri | http://hdl.handle.net/2164/7656 | |
dc.description | Professor Matteo Zanda and Professor Marcel Jaspars are gratefully acknowledged for the use of the NMR system and Russell Gray for running some of the NMR samples. | en |
dc.format.extent | 817095 | |
dc.language.iso | eng | |
dc.relation.ispartof | Scientific Reports | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | cancer imaging | en |
dc.subject | drug development | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy : routes to glycogen synthase kinase 3 | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Education | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Aberdeen Biomedical Imaging Centre | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | https://doi.org/10.1038/srep36544 | |
dc.identifier.vol | 6 | en |